Clinical Trials Logo

Clinical Trial Summary

In this study, we will use the SpotLight-19 device in patients presenting to a coronavirus disease (COVID-19) Assessment Centre for polymerase chain reaction (PCR) testing. Consenting patients will undergo a Spotlight-19 scan. We will link the scan to PCR results, age, vaccination status, and COVID-19 symptoms in order to calibrate the SpotLight-19 prediction algorithm of a state of COVID-19 infection.


Clinical Trial Description

Implementation of rapid, accessible, and accurate COVID-19 testing is a cornerstone of public health efforts to contain and respond to the spreading virus. To respond to this need, ISBRG Corp is applying its SpotLight-19 device to the challenge of developing a non-invasive screening test for COVID-19. The SpotLight-19 device is designed to use non-invasive visible and near-infrared (NIR) spectroscopic measurements of an individual's fingertip and an artificial intelligence technology platform calibrated using viral diagnostic measurements to identify and recognize a spectral fingerprint specific to COVID-19. All individuals (3yrs or older) presenting to designated hospital COVID-19 Assessment Centres in Ottawa will be recruited to participate. Only people with extreme fingertip scarring will be excluded. Consenting participants will undergo a scan using the SpotLight-19 device - this includes a Fitzpatrick Skin Assessment and 10-20 second scans of the fingertip with the SpotLight-19 device. Following the scan participants will undergo a PCR test as per usual care. The PCR result, participant age, COVID-19 vaccination status, and presence of COVID-19 symptoms will be collected from the medical record and shared with ISBRG Corp. A minimum of 250 COVID-19 positive and a minimum of 250 COVID-19 negative as determined by PCR will be sought. The number of enrolled participants to achieve the sample size will depend on the COVID-19 positivity rate. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05198869
Study type Interventional
Source Ottawa Hospital Research Institute
Contact Alison Jennings
Phone 6137985555
Email [email protected]
Status Recruiting
Phase N/A
Start date December 29, 2021
Completion date July 31, 2022

See also
  Status Clinical Trial Phase
Recruiting NCT05120167 - Strategies for Endocervical Canal Investigation in Women With Abnormal Screening Cytology and Negative Colposcopy N/A
Completed NCT01820234 - Evaluation of Store-and-Forward Teledermatology Versus a Face-to-Face Assessment During a Skin Cancer Screening Event N/A
Completed NCT01140022 - Leveraging Technology as a Clinician Extender to Screen Culturally Diverse Young Women for Chlamydia N/A
Completed NCT04240418 - Initiative in LYon for Lung cAncer Screening Development - Prevalence Study
Recruiting NCT03937583 - Screening for Cancer in Patients With Unprovoked VTE Phase 4
Completed NCT00115557 - Delivery of Preventive Services in Primary Care N/A
Completed NCT02727894 - Colorectal Cancer: Screening vs. Non-Screening
Active, not recruiting NCT03861741 - A Study to Evaluate the Feasibility of Screening Relatives of Patients Affected by Non-Syndromic Thoracic Aortic Diseases N/A
Recruiting NCT04644874 - Geriatric Oncology Screening of Older Patients With Solid Cancers
Recruiting NCT05056831 - Efficacy of an Adapted Multicomponent Physical Activity Intervention to Reduce Psychosocial Distress in Rural Adults Following Cancer Diagnosis N/A
Completed NCT01626703 - Effect of Depressin Screening and Care Program at Community Health Center N/A
Recruiting NCT00941538 - Screening for Nasopharyngeal Carcinoma in High Risk Populations N/A
Completed NCT00582829 - Colorectal Cancer Screening Intervention for Family Members of Colorectal Cancer Patients Phase 0
Active, not recruiting NCT04171830 - Clinical Surveillance Tool to Screen for Unmet Palliative Needs Among Patients in the Final Year of Life N/A
Completed NCT04684316 - Economic Evaluation of Periodic Occupational Health Screening N/A
Completed NCT01427829 - Computer-assisted Psychosocial Risk Assessment (CaPRA) for Refugee Health and Settlement N/A
Recruiting NCT04221854 - Stool-based SDC2 DNA Methylation Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer N/A
Recruiting NCT04935710 - Prevention and Early Identification for High Risk Youth in School-based Clinics Phase 1
Active, not recruiting NCT02849041 - Screening of Tobacco-induced Cancers by Low-dose CT-scanner and Identification of Circulating Tumor Cells N/A
Recruiting NCT02288676 - DOvEEgene: Diagnosing Ovarian and Endometrial Cancer Early Using Genomics